The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. Key drivers contributing to the market growth are the rise in adoption of sequencing platforms in clinical diagnostics, growth in genomics and enzymology-based research, and increasing investments in R&D pertaining to molecular biology and precision medicine. Also, the growing collaborations between different companies and organizations in the biotech industry is one of the factors driving the market. The development of personalized medicine is another important factor that drives revenue generation in the market for nucleic acid isolation and purification. However, the high cost of automated instruments is expected to hinder the growth of the market.
The nucleic acid isolation and purification market is well established owing to the dominance of prominent market players, such as QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and Roche AG (Switzerland). Other prominent players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
To know about the assumptions considered for the study download the pdf brochure
QIAGEN N.V. (Netherlands) was the largest player in the nucleic acid isolation and purification market in 2021. The dominant position of the company can be attributed to its strong brand image and robust product portfolio. The company focuses on organic and inorganic growth strategies to maintain its position in the market and expand its global presence. The company focuses on expansion in order to create a strong foothold in the market. In 2018, the company opened QIAGEN Business Services (QBS) Manila, its new shared service center, in the Philippines. This center will provide services related to supply chain management, customer care, accounting, technical services, and other sales support activities. The company is undertaking several initiatives to expand their DNA or RNA extraction instruments and kits. For instance, in January 2020, QIAGEN stated that it has completed 2,500 placements of its QIAsymphony instrument. These placements represent a great milestone for QIAGEN’s magnetic bead-based instruments. QIAsymphony has the broadest test portfolio of any platform in its category in the European market.
Thermo Fisher Scientific (US) is the second-leading player in the global nucleic acid isolation and purification market. The company focuses on organic and inorganic growth strategies to maintain its position in the market and expand its global presence. For instance, the company announced the acquisition of QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies. This acquisition is expected to expand the company’s specialty diagnostics portfolio with innovative sample preparation, assay, and bioinformatics technologies, in March 2020. Also, in April 2019, MagMax isolation kits based on magnetic bead technology were developed by Thermo Fisher. Such kits are used to isolate RNA and DNA in samples of flora, microorganisms, viral, and gram-negative bacteria.
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE